Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

S. Korea's Medical Charity Program Bolsters Care for Int'l Child Patients

September 8, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

SEOUL, South Korea, Sept. 8, 2011 /PRNewswire-Asia/ -- The Ministry of Health and Welfare (Minister: Chin Soo-hee) and the Korea Health Industry Development Institute (KHIDI, President: Ko Kyung-hwa) plan to invite 25 international child patients, from seven countries, to Korea over the...

Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes

September 7, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 7, 2011 /- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY ) will present the latest data from their diabetes portfolio at the 47th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Lisbon, Portugal,...

Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons

September 7, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

LAKE SUCCESS, N.Y., Sept. 7, 2011 /- As NFL coaches and players face a dramatically shortened pre-season to ramp-up their strength and conditioning programs, one team's preparation will be gaining a competitive edge as it defends its NFC South title during the 2011 NFL season. Today,...

Advertisement

ThermoGenesis Presentation at Rodman & Renshaw Conference

September 7, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

RANCHO CORDOVA, Calif., Sept. 7, 2011 /- ThermoGenesis Corp. (NASDAQ: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, announced today that it will be participating in the Rodman & Renshaw 13th Annual Healthcare Conference on...

Cardiosolutions pumps up war chest with new funding

September 6, 2011 12:35 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Medical device company Cardiosolutions Inc. of West Bridgewater, has raised $3.3 million of what it plans as a $6.5 million funding round, the first funding the company has taken in since late 2009.

HeartSine® Technologies Named One of the Most Innovative Businesses in the United Kingdom

September 6, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

NEWTOWN, Pa., Sept. 6, 2011 /- HeartSine ® Technologies, Inc., a world leader in personal and public access defibrillators, announced that it is a finalist to receive the coveted Orange Innovation Award in the 10th annual UK National Business Awards. HeartSine was selected because...

Omthera Pharmaceuticals, Inc. to Present at the Rodman and Renshaw 13th Annual Healthcare Conference

September 6, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

BEDMINSTER, N.J., Sept. 6, 2011 /- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that Jerry Wisler, President and Chief Executive Officer, will present at the Rodman and Renshaw 13th Annual Healthcare Conference, on September...

Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients

September 6, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., Sept. 6, 2011 /- Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced positive results from a Phase I U.S. clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have...

Advertisement

Webcast Alert: Isis Pharmaceuticals Hosts Dr. John Kastelein to Review Mipomersen Long-term Data Recently Presented at ESC Congress 2011

September 6, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Sept. 6, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announces the following webcast:What: Data from Mipomersen's Open-Label Extension Study presented at ESCWhen: Wednesday, September 07, 2011 at 12:00 p.m. ET / 9:00 a.m. PTWhere: www.isispharm.comHow: ...

Patients Needing Heart Tests Should Talk to Their Doctors About Radiation-Free Diagnostic Options, Including Cardiovascular Ultrasound

September 6, 2011 12:34 pm | by Bio-Medicine.Org | News | Comments

MORRISVILLE, N.C., Sept. 6, 2011 /PRNewswire-USNewswire/ -- Two recent publications, a Sentinel Alert on the dangers of medical radiation by The U.S. Joint Commission and an article entitled "The Business of Healing Hearts" published in the September issue of Consumer Reports magazine,...

NIH-Funded Study Demonstrates That Patients Receiving New CPR Devices (ResQPOD® and ResQPump™) and Cooling Have Improved Long-Term Brain Function Following Cardiac Arrest

September 6, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

ROSEVILLE, Minn., Sept. 6, 2011 /- Today, Advanced Circulatory Systems Inc. (ACSI) announced results from a large, NIH-funded clinical trial comparing standard cardiopulmonary resuscitation (CPR) to a new method of CPR that provides greater protection to the heart and brain when the heart...

Golden Meditech Celebrates Grand Opening of Taiwan Representative Office

September 6, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

HONG KONG, Sept. 6, 2011 /PRNewswire-Asia/ -- Golden Meditech Holdings Limited ("Golden Meditech", together with its subsidiaries collectively as the "Group", - 801.HK; 910801.TW), which embodies a leading medical devices enterprise, a major brand name in haematology hospital and the...

China Cord Blood Corporation Announces Participation in Upcoming Investor Conferences

September 6, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

HONG KONG, Sept. 6, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO ) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the...

Advertisement

Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or 'Off-The-Shelf' Stem Cell Treatment for Heart Attacks

September 5, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

MELBOURNE, Australia, Sept. 5, 2011 /- Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead...

U.S. Market for Emergency Room Equipment 2011

September 5, 2011 1:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 5, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: U.S. Market for Emergency Room Equipment 2011 ...

Hurricane Irene Spurs Emergency Home Medical Services for Patients

September 2, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Sept. 2, 2011 /PRNewswire-USNewswire/ -- From the Carolinas to New England, many providers of durable medical equipment and services spent the past week preparing their customers for and responding to the havoc created by Hurricane Irene.  Of particular concern to...

Roche Diabetes Care Celebrates Second Annual Infusion Site Awareness Week, Aug. 29-Sept. 4

September 1, 2011 12:34 pm | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, Sept. 1, 2011 /- Roche Diabetes Care, makers of the ACCU-CHEK® portfolio of diabetes management products and services, is proud to host its second annual Infusion Site Awareness Week, Aug. 29-Sept. 4, a week-long effort to highlight the importance of proper infusion...

Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies

September 1, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

ANNAPOLIS, Md., Sept. 1, 2011 /- This month, Floridians are recognizing "Plasma Protein Therapies Month," by raising awareness for the valuable contributions of plasma donors throughout the "Sunshine State" and for the rare, genetic diseases treated with the therapies that are made...

Californians Recognized For Role In Helping Rare Disease Patients Who Need Lifesaving Therapies

September 1, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

ANNAPOLIS, Md., Sept. 1, 2011 /- This month, Californians are recognizing "Plasma Protein Therapies Month," by raising awareness for the valuable contributions of plasma donors throughout the "Golden State" and for the rare, genetic diseases treated with the therapies that are made...

Californians and Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies

September 1, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

ANNAPOLIS, Md., Sept. 1, 2011 /- This month, Florida and California are recognizing "Plasma Protein Therapies Month," by raising awareness for the valuable contributions of plasma donors and for the rare, genetic diseases treated with the therapies that are made possible through plasma...

diaDexus to Present at the RW Baird 2011 Health Care Conference

September 1, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, Calif., Sept. 1, 2011 /- diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans...

New Polar Move Heart Rate Monitor for Students Facilitates Effective and Safe Physical Education

September 1, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

LAKE SUCCESS, N.Y., Sept. 1, 2011 /- Polar ( www.polarusa.com ), the leader in heart rate monitoring and fitness assessment technologies, today introduced the Polar Move . The new heart rate monitor is designed specifically around the needs of the education market. Its introduction...

Leading Expert's Heart Health Advice: Flush Your "Flush-Free" Dietary Supplement Niacin

September 1, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

MAPLE GROVE, Minn., Sept. 1, 2011 /- People seeking support for healthy good cholesterol from a "flush-free" niacin supplement, prepare to be disappointed – and to make a return trip to your local pharmacy. According to leading cardiologist, Dr. Carl Lavie, medical director of...

Isis Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011

September 1, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Sept. 1, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Stifel Nicolaus' Healthcare Conference 2011 on Thursday, September 08, 2011 at 2:05 p.m. ET at the Four...

Volcano Corporation Announces Presentations at Upcoming Investor Conferences

September 1, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 1, 2011 /- Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading